Search
for
Sort by
Research 571–600 of 1000+
- UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO
- Relatório de Estágio realizado na Farmácia Santiago
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Alopecia in Belgian Blue crossbred calves: a case series
- Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Polycystic Ovary Syndrome
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging
- Drug-Induced Skin, Nail and Hair Disorders
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Niosomes as a propitious carrier for topical drug delivery
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Cutaneous Side Effects of Oral Contraceptives
- Alternative uses of dermoscopy in daily clinical practice: An update
- Stress and Psychoneuroimmunologic Factors in Dermatology
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Alterations in Hair Follicle Dynamics in Women
- INTERFERONS IN DERMATOLOGY
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population
- Oral vitamin A as an adjunct treatment for canine sebaceous adenitis
- Psychoactive drugs and skin
- Anaemia and skin disease
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Drug eruptions in dermatology
- Systemic Autoimmune Diseases
- Herbal Treatment for Dermatologic Disorders
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Approach to Patients with Suspected Rheumatic Disease